AC
DICE

Aaron Cowen’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Aaron Cowen’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-410,000
Closed -$10.4M – 109
2021
Q4 		$10.4M Hold
410,000
– – 0.2% 62
2021
Q3 		$13.4M Buy
+410,000
New +$14M 0.23% 56

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Aaron Cowen's DICE Position: Q1 2022 in Review

Aaron Cowen sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q1 2022, closing a stake of 410,000 shares — an estimated $10.4M sold.

Aaron Cowen first reported a position in DICE in Q3 2021 and held it in 2 quarters. The position peaked at $13.4M in Q3 2021. 76 funds tracked by Wall St. Rank hold DICE as of Q1 2022.

  • Aaron Cowen reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Aaron Cowen sold 410,000 DICE Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $10.4M.
  • Aaron Cowen first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Aaron Cowen's DICE Therapeutics, Inc. Common Stock position peaked at $13.4M in Q3 2021.
  • 76 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Suvretta Capital Management's 13F filing for Q1 2022, filed 16 May 2022.